Longitudinal Analysis of Biochemical, Imaging, and Adenoma Size Changes in Primary Hyperparathyroidism
Experimental and Clinical Endocrinology & Diabetes · 2026-02 · 134 (02) · 53-62
DOI: 10.1055/a-2804-1682 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, online erschienen am 05.03.2026. Verfasst von Berçem Ayçiçek und 28 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Metabolism, Istinye University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Parathyroid Neoplasms, Adenoma.
Abstract (Originalsprache)
Background
Primary hyperparathyroidism (PHPT) is a prevalent endocrine disorder characterized by disrupted calcium–phosphorus homeostasis. Accurate biochemical assessment, including albumin-corrected calcium, and preoperative localization of parathyroid adenomas are essential for optimal management. This study aimed to evaluate temporal changes in imaging detectability, biochemical markers, and adenoma size, and to assess novel biochemical indices in patients with asymptomatic PHPT (aPHPT).
Methods
In this multicenter retrospective study, 416 aPHPT patients underwent clinical, biochemical, and radiological evaluation at three time points. Biochemical parameters included albumin-corrected calcium, phosphorus, parathyroid hormone (PTH), 25-hydroxyvitamin D, alkaline phosphatase (ALP), and 24-hour urinary calcium. Novel indices—calcium/phosphorus (Ca/P), PTH/phosphorus (PTH/P), and calcium×chloride/phosphorus (Ca×Cl/P)—were calculated to evaluate diagnostic and predictive value. Imaging included high-resolution neck ultrasonography, 99mTc-sestamibi SPECT/CT, and four-dimensional CT to assess adenoma detectability and size changes. Statistical analyses included repeated-measures ANOVA or Friedman tests for temporal comparisons, correlation analyses, logistic regression for predictors of adenoma detection, and ROC curves to evaluate diagnostic accuracy. A p-value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Endocrinology and Metabolism, Istinye University, Istanbul, Turkey.
- Endocrinology and Metabolism Disease, Umraniye Training and Research Hospital, Istanbul, Turkey.
- Endocrinology, Ümraniye Eğitim Ve Araştırma Hastanesi, Istanbul, Turkey.
- Ankara University, Ankara, Turkey.
- Yildirim Beyazit University, Ankara, Turkey.
- Ankara Diskapi Yildirim Beyzat Training and Research Hospital, Ankara, Turkey.
ORCID-Profile: Berçem Ayçiçek, İsmail Engin
Zitieren
APA
Ayçiçek, B., Tuna, M. M., Engin, İ., Gökçay Canpolat, A., Yiğit, E., Fırat, S. N., Kır, Y., Yeşiltepe, A., Çınar, N., Sakar, K., Bahadır, Ç. T., Güneş, Ş., Kubat, A., Tufan, C., Saygili, E. S., Candemir, D. K., Karahan, A., Görgel, A., Alphan, Z. Ü., …, & Elbüken, G. (2026). Longitudinal Analysis of Biochemical, Imaging, and Adenoma Size Changes in Primary Hyperparathyroidism. Experimental and Clinical Endocrinology & Diabetes, 134(02), 53-62. https://doi.org/10.1055/a-2804-1682
Vancouver
Ayçiçek B, Tuna MM, Engin İ, Gökçay Canpolat A, Yiğit E, Fırat SN, et al. Longitudinal Analysis of Biochemical, Imaging, and Adenoma Size Changes in Primary Hyperparathyroidism. Experimental and Clinical Endocrinology & Diabetes. 2026;134(02):53-62. doi:10.1055/a-2804-1682
BibTeX
@article{Ayiek2026,
author = {Ayçiçek, Berçem and Tuna, Mazhar Müslüm and Engin, İsmail and Gökçay Canpolat, Asena and Yiğit, Ekin and Fırat, Sevde Nur and Kır, Yusuf and Yeşiltepe, Ali and Çınar, Neşe and Sakar, Kenan and Bahadır, Çiğdem Tura and Güneş, Şevkican and Kubat, Ayse and Tufan, Ceren and Saygili, Emre Sedar and Candemir, Dilek Kılınç and Karahan, Aysenur and Görgel, Ahmet and Alphan, Ziynet Üç and Konak, Yudum Yaprak Usda and Fenkci, Semin and Aydemir, Mustafa and Karatoprak, Kadircan and Şahin Kimyon, Özge and Boz, Oğulcan and Gürlek, Alper and Uzun, Özden and Özbay, Ümit Nur and Elbüken, Gülşah},
title = {Longitudinal Analysis of Biochemical, Imaging, and Adenoma Size Changes in Primary Hyperparathyroidism},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2026},
volume = {134},
number = {02},
pages = {53--62},
doi = {10.1055/a-2804-1682}
}
EUVIMED